Speaker illustration

Doctor Satoshi Tokimasa

Chiba University Hospital, Chiba (Japan)

Multicenter research of bleeding risk between low dose prasugrel and standard dose clopidogrel in patients with coronary artery disease undergoing percutaneous coronary intervention

Event: ESC Congress 2017

Topic: Thrombosis and platelets

Session: Acute coronary syndromes

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb